Cancer chemotherapy
By: Howard E. Skipper.
Contributors: Southern Research Institute (Birmingham, Ala.); American Society of Clinical Oncology.
Series: Monograph publishing : Sponsor series
Publisher: Published for American Society of Clinical Oncology by University Microfilms International
Published: 1978
Place of publication: Ann Arbor, Mich
Language: eng
Number of pages: 10
Subjects: Cancer -- Chemotherapy.; Antineoplastic agents.; Neoplasms -- Drug therapy.
Notes: On cover: Southern Research Institute.
Table of contents: title: v. 1. Reasons for success and failure in treatment of murine leukemias with the drugs now employed in treating human leukemias.; title: v. 2. On reducing treatment failures due to overgrowth of specifically and permanently drug-resistant neoplastic cells.; title: v. 3. Idealized hypothetical illustrations of the effects of specifically drug-resistant leukemia cells on end-results achievable with single drugs and combinations.; title: v. 4. A review and more quantitative analysis of the results of many internally controlled combination chemotherapy trials carried out over the past fifteen years (L1210 leukemia and P388 leukemia).; title: v. 5. Ridgway osteogenic sarcoma; response at different stages to surgery, single drugs, combinations of drugs and surgery-chemotherapy.; title: v. 6. Lewis lung carcinoma; response to surgery, chemotherapy, and surgery-chemotherapy.; title: v. 7. Colon tumor 26; response to surgery, chemotherapy, and surgery-chemotherapy.; title: v. 8. Comparative trials showing the response of animals bearing mammary tumors 16/C and line 44 to chemotherapy, surgery, and surgery plus chemotherapy.; title: v. 9. Concurrent comparisons of some 2-, 3-, and 4-drug combinations delivered simultaneously and sequentially (L1210 and P388 leukemia systems).; title: v. 10. Some thoughts regarding the modes of action of drugs on cells and on application of available pharmacokinetic data (anticancer drugs).